Multidrug-resistant nontyphoidal Salmonella in New York state's foodborne diseases active surveillance network counties

Foodborne Pathogens and Disease

Volumn 7, Issue 2, 2010, Pages 167-173

  Solghan, Suzanne M ^a   Dumas, Nellie B ^b   Root, Timothy P ^b   Quinlan, Tammy M ^b   Armstrong, Leeanna R ^b   Spina, Nancy L ^a   Zansky, Shelley M ^a  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE;

AFRICAN AMERICAN; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAUCASIAN; HOSPITALIZATION; LENGTH OF STAY; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SALMONELLA; SALMONELLA TYPHIMURIUM; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHNIC GROUPS; FEMALE; FOOD CONTAMINATION; FOOD MICROBIOLOGY; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEW YORK; SALMONELLA; SALMONELLA FOOD POISONING; SENTINEL SURVEILLANCE; YOUNG ADULT;

SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR NEWPORT; SALMONELLA TYPHIMURIUM;

EID: 76749091420     PISSN: 15353141     EISSN: None     Source Type: Journal    
DOI: 10.1089/fpd.2009.0329     Document Type: Article

References (31)

1. Anderson AD, Nelson JM, Rossiter S, and Angulo FJ. Public health consequences of use of antimicrobial agents in food animals in the United States. Microb Drug Resist 2003;9:373-379.
2. Angulo FJ, Johnson KR, Tauxe RV, and Cohen ML. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist 2000;6:77-82.
3. Arshad MM, Wilkins MJ, Downes FP, Rahbar MH, Erskine RJ, Boulton ML, and Saeed AM. A registry-based study on the association between human Salmonellosis and routinely collected parameters in Michigan, 1995-2001. Foodborne Pathog Dis 2007;4:16-25.
4. Bauer AW, Kirby MMW, Sherris JC, and Turck M. Antibiotic susceptibility testing by a standard single disk method. Am J Clin Pathol 1966;45:493-496.
5. [CDC] Centers for Disease Control and Prevention. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): 2006 Human Isolates Final Report. Atlanta, GA: U.S. Department of Health and Human Services, CDC, 2009.
6. [CDC] Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of infections with pathogens transmitted commonly through food-10 states, 2008. MMWR 2009; 58:333-337.
7. [CLSI] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testing: Nineteenth Informational Supplement [M100-S19]. Wayne PA: Clinical and Laboratory Standards Institute 2009.
8. Coburn B, Grassl GA, and Finlay BB. Salmonella, the host and disease: a brief review. Immunol Cell Biol 2007;85:112-118.
9. Cohen ML and Tauxe RV. Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science 1986;234: 964-969.
10. Cornell University Animal Health Diagnostic Center. Animal Health Advisory: Multi-Drug-Resistant Salmonella Dublin in Cattle. Ithaca, NY: Cornell University, 2006.
11. Devasia RA, Varma JK, Whichard J, Gettner S, Cronquist AB, Hurd S, Segler S, Smith K, Hoefer D, Shiferaw B, Angulo FJ, and Jones TF. Antimicrobial use and outcomes in patients with multidrug-resistant and pansusceptible Salmonella Newport infections, 2002-2003. Microb Drug Resist 2005;11:371-377.
12. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, and Angulo FJ. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl J Med 1998;338:1333-1338.
13. Gupta A, Fontana J, Crowe C, Bolstorff B, Stout A, Van Duyne S, Hoekstra MP, Whichard JM, Barrett TJ, and Angulo FJ. Emergence of multi-drug resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis 2003;188: 1707-1716.
14. Hakanen A, Kotilainen P, Jalava J, Siitonen A, and Huovinen P. Detection of decreased fluoroquinolones susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 1999;37:3572-3577.
15. Helms M, Ethelberg S, Mølbak K, and DT104 Study Group. International Salmonella Typhimurium DT104 Infections, 1992-2001. Emerg Infect Dis 2005;11:859-867.
16. Helms M, Vastrup P, Gerner-Smidt P, and Mølbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002;8:490-495.
17. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001;32:263-269.
18. Jones TF, Ingram LA, Cieslak PR, Vugia DJ, Tobin-D'Angelo M, Hurd S, Medus C, Cronquist A, and Angulo FJ. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 2008; 198:109-114.
19. Lee LA, Puhr ND, Maloney EK, Bean NH, and Tauxe RV. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. J Infect Dis 1994;170:128-134.
20. Lewin CS, Nandivada LS, and Amyes SG. Multiresistant Salmonella and fluoroquinolones. J Antimicrob Chemother 1991;27: 147-149.
21. McEwen SA and Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis 2002;34:S93-S106.
22. Stevenson JE, Gay K, Barrett TJ, Medalla F, Chiller TM, and Angulo FJ. Increase in nalidixic acid resistance among nontyphi Salmonella enterica isolates in the United States from 1996-2003. Antimicrob Agents Chemother 2007;51:195-197.
23. Szych J, Cieślik A, Paciorek J, and Kałuzewski S. Antibiotic resistance in Salmonella enterica subsp. Enterica strains isolated in Poland from 1998 to 1999. Int J Antimicrob Agents 2001; 18:37-42.
24. Threlfall EJ. Antimicrobial drug resistance in Salmonella: problems and perspectives in food-and water-borne infections. FEMS Microbiol Rev 2002;26:141-148.
25. Travers K and Barza M. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis 2002;34:S131-S134.
26. Varma JK, Marcus R, Stenzel SA, Hanna SS, Gettner S, Anderson BJ, Hayes T, Shiferaw B, Crume TL, Joyce K, Fullerton KE, Voetsch AC, and Angulo FJ. Highly resistant Salmonella Newport MDR-AmpC transmitted through the domestic US food supply: a FoodNet case-control study of sporadic Salmonella Newport infections, 2002-2003. J Infect Dis 2006;194:222-230.
27. Varma JK, Mølbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T, Smith KE, Vugia DJ, Chang HH, and Angulo FJ. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005;191:554-561.
28. Voetsch AC, Van Gilder TJ, Angulo FJ, Farley MM, Shallow S, Marcus R, Cieslak PR, Deneen VC, and Tauxe RV. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis 2004;38: S127-S134.
29. Vugia DJ, Samuel M, Farley MM, Marcus R, Shiferaw B, Shallow S, Smith K, and Angulo FJ. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis 2004;38:S149-S156. (Pubitemid 38553319)
30. Werner SB, Humphrey GL, and Kamei I. Association between raw milk and human Salmonella Dublin infection. Br Med J 1979;2:238-241.
31. [WHO] World Health Organization. 1st Joint FAO=OIE=WHO Expert Workshop on Non-human Antimicrobial Usage and Antimicrobial Resistance: Scientific Assessment, Geneva, December 1-5, 2003. Geneva, World Health Organization, 2004.